Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey

Neurology

Volumn 53, Issue 2, 1999, Pages 424-427

  Tanne, David ^a,l   Bates, V E ^b   Verro, P ^c   Kasner, S E ^d   Binder, J R ^e   Patel, S C ^a   Mansbach, H H ^a   Daley, S ^a   Schultz, L R ^a   Karanjia, P N ^f   Scott, P ^g   Dayno, J M ^h   Vereczkey Porter, K ^b   Benesch, C ⁱ   Book, D ^e   Coplin, W M ^j   Dulli, D ^k   Levine, S R ^a  

^a HENRY FORD HOSPITAL   (United States)

^b DENT NEUROLOGIC INSTITUTE   (United States)

^c New Jersey Neuroscience Institute   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f MARSHFIELD CLINIC   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

ⁱ STRONG MEMORIAL HOSPITAL   (United States)

^j DETROIT RECEIVING HOSPITAL   (United States)

^k UNIVERSITY OF WISCONSIN MADISON   (United States)

^l SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0033595255     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.2.424     Document Type: Article

References (8)

1. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke - a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1996;27:1711-1718.
2. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Thrombolytic therapy for acute ischemic stroke: summary statement. Neurology 1996;47:835-839.
3. National Institute for Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1588.
4. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118.
5. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997;28:2119-2125.
6. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology 1998;50:883-890.
7. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke. Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
8. Grond M, Stenzel C, Schmülling S, et al. Early intravenous thrombolysis for acute ischemic stroke in a community based approach. Stroke 1998;29:1544-1549.